{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825895508157184.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/s0140-6736(19)31774-x"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S014067361931774X?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S014067361931774X?httpAccept=text/plain"}}],"dc:title":[{"@value":"Antibody–drug conjugates for cancer"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382825895508157186","@type":"Researcher","foaf:name":[{"@value":"Cindy H Chau"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895508157184","@type":"Researcher","foaf:name":[{"@value":"Patricia S Steeg"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895508157185","@type":"Researcher","foaf:name":[{"@value":"William D Figg"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"01406736"}],"prism:publicationName":[{"@value":"The Lancet"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2019-08","prism:volume":"394","prism:number":"10200","prism:startingPage":"793","prism:endingPage":"804"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S014067361931774X?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S014067361931774X?httpAccept=text/plain"}],"createdAt":"2019-08-29","modifiedAt":"2025-09-26","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050581168899941504","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Cancer-Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat Conjugates"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168834964352","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Visualization of Intratumor Pharmacokinetics of [fam-] Trastuzumab Deruxtecan (DS-8201a) in HER2 Heterogeneous Model Using Phosphor-integrated Dots Imaging Analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017280652704256","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"SLC46A3 is a lysosomal proton-coupled steroid conjugate and bile acid transporter involved in transport of active catabolites of T-DM1"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021390755792256","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Development of potent antibody drug conjugates against ICAM1+ cancer cells in preclinical models of cholangiocarcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025430194855424","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"PBMC-engrafted humanized mice models for evaluating immune-related and anticancer drug delivery systems"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617452428416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Shortwave-infrared (SWIR) fluorescence molecular imaging using indocyanine green–antibody conjugates for the optical diagnostics of cancerous tumours"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643760399488","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Shortwave-Infrared Fluorescent Molecular Imaging Probes Based on π-Conjugation Extended Indocyanine Green"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302866841997824","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Exploring a Nuclear-Selective Radioisotope Delivery System for Efficient Targeted Alpha Therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360303782144989312","@type":"Article","resourceType":"preprint","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306905606888320","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pathological and Biological Significance of the Specific Glycan, TRA-1-60, on Aggressive Gastric Adenocarcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580232381170304","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"In Vitro and In Vivo Fluorescence Imaging of Antibody–Drug Conjugate-Induced Tumor Apoptosis Using Annexin V–EGFP Conjugated Quantum Dots"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580232421809408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Near‐infrared‐induced drug release from antibody–drug double conjugates exerts a cytotoxic photo‐bystander effect"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580232432683520","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Do antibody–drug conjugates increase the risk of sepsis in cancer patients? A pharmacovigilance study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584341810032384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Design, synthesis, and biological evaluation of phenylcyclopropylamine-entinostat conjugates that selectively target cancer cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567405857152","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Dual-colour (near-infrared/visible) emitting annexin V for fluorescence imaging of tumour cell apoptosis <i>in vitro</i> and <i>in vivo</i>"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567837833856","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"True significance of N-acetylglucosaminyltransferases GnT-III, V and α1,6 fucosyltransferase in epithelial-mesenchymal transition and cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861704790830208","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861705563552896","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Shortwave-infrared (SWIR) emitting annexin V for high-contrast fluorescence molecular imaging of tumor apoptosis in living mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865816800447232","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Biocompatible and Water-Soluble Shortwave-Infrared (SWIR)-Emitting Cyanine-Based Fluorescent Probes for In Vivo Multiplexed Molecular Imaging"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865816805412224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"bioTCIs: Middle-to-Macro Biomolecular Targeted Covalent Inhibitors Possessing Both Semi-Permanent Drug Action and Stringent Target Specificity as Potential Antibody Replacements"}]},{"@id":"https://cir.nii.ac.jp/crid/1390861173498543616","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Fundamental Study for the Development of Stationary Phases Toward the Selective Separation of Antibody-drug Conjugates"},{"@language":"ja","@value":"抗体薬物複合体の選択的分離に向けた固定相開発の基礎検討"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/s0140-6736(19)31774-x"},{"@type":"CROSSREF","@value":"10.1158/1078-0432.ccr-21-0397_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"},{"@type":"CROSSREF","@value":"10.1093/pnasnexus/pgac063_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"},{"@type":"CROSSREF","@value":"10.1038/s41698-023-00447-z_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"},{"@type":"CROSSREF","@value":"10.3389/fmolb.2024.1447315_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"},{"@type":"CROSSREF","@value":"10.1039/d0ra04710d_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"},{"@type":"CROSSREF","@value":"10.1021/acs.bioconjchem.1c00253_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"},{"@type":"CROSSREF","@value":"10.3390/ijms24119593_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"},{"@type":"CROSSREF","@value":"10.1101/2021.12.23.474044_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"},{"@type":"CROSSREF","@value":"10.1016/j.labinv.2024.102073_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"},{"@type":"CROSSREF","@value":"10.1021/acsomega.1c05636_references_DOI_83FZYnrrwC5am4xwBexZLDefxFI"},{"@type":"CROSSREF","@value":"10.1002/btm2.10388_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"},{"@type":"CROSSREF","@value":"10.3389/fphar.2022.967017_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"},{"@type":"CROSSREF","@value":"10.1016/j.bmc.2024.117632_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"},{"@type":"CROSSREF","@value":"10.1039/d0ra06495e_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"},{"@type":"CROSSREF","@value":"10.1016/j.mam.2020.100905_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"},{"@type":"CROSSREF","@value":"10.2116/bunsekikagaku.72.357_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"},{"@type":"CROSSREF","@value":"10.1021/acsmedchemlett.2c00126_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"},{"@type":"CROSSREF","@value":"10.1016/j.celrep.2022.110839_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"},{"@type":"CROSSREF","@value":"10.1039/d2ra03315a_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"},{"@type":"CROSSREF","@value":"10.1021/acsami.4c01000_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"},{"@type":"CROSSREF","@value":"10.3390/ijms24043525_references_DOI_K9DtR1Vps1EUUHoqeU9eW2ypnWR"}]}